Porton Pharma Solutions (300363.SZ) Earnings Analysis
Porton Pharma Solutions (300363.SZ) next reports earnings on 2026-08-17. Trailing P/E 64.58.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 300363.SZ next report earnings?
| Next earnings date | 2026-08-17 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
300363.SZ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-04 | 0.0303 CNY | n/a | n/a | n/a |
| 2025-10-24 | 0.09749 CNY | n/a | n/a | n/a |
| 2025-04-24 | -0.01 CNY | n/a | n/a | n/a |
| 2024-10-24 | -0.07 CNY | n/a | n/a | n/a |
300363.SZ valuation and analyst view
| Trailing P/E | 64.58 |
|---|---|
| Trailing EPS | 0.23699 CNY |
| Price / book | 1.65 |
| Dividend yield | 0.55% |
| Market cap | 9.05B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Porton Pharma Solutions (300363.SZ)'s next earnings date?
Porton Pharma Solutions is next scheduled to report on 2026-08-17.
Did 300363.SZ beat earnings last quarter?
Consensus estimate data was not available for 300363.SZ's 2026-04-04 report.
What is 300363.SZ's current P/E ratio and EPS?
300363.SZ trades at a trailing P/E of 64.58 on trailing EPS of 0.23698526563145447 CNY.
What do analysts rate 300363.SZ?
300363.SZ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.